Vallon Pharmaceuticals VLON Stock
Vallon Pharmaceuticals Price Chart
Vallon Pharmaceuticals VLON Financial and Trading Overview
| Vallon Pharmaceuticals stock price | 0.4 USD |
| Previous Close | 0.46 USD |
| Open | 0.42 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 2200 |
| Day's Range | 0.38 - 0.43 USD |
| 52 Week Range | 0.21 - 16.5 USD |
| Volume | 1.11M USD |
| Avg. Volume | 8.09M USD |
| Market Cap | 5.39M USD |
| Beta (5Y Monthly) | -1.148559 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12 USD |
VLON Valuation Measures
| Enterprise Value | 1.61M USD |
| Trailing P/E | N/A |
| Forward P/E | 2.3529413 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.2988508 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.24 |
Trading Information
Vallon Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -1.148559 |
| 52-Week Change | 883.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 16.5 USD |
| 52 Week Low | 0.21 USD |
| 50-Day Moving Average | 2.23 USD |
| 200-Day Moving Average | 0.8 USD |
VLON Share Statistics
| Avg. Volume (3 month) | 8.09M USD |
| Avg. Daily Volume (10-Days) | 135.25K USD |
| Shares Outstanding | 13.48M |
| Float | 8.57M |
| Short Ratio | 0.11 |
| % Held by Insiders | 23.41% |
| % Held by Institutions | 13.28% |
| Shares Short | 90.7K |
| Short % of Float | 1.01% |
| Short % of Shares Outstanding | 0.67% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.35% |
| Return on Equity (ttm) | -172.15% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -6722000 USD |
| Net Income Avi to Common (ttm) | -7024000 USD |
| Diluted EPS (ttm) | -15.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.78M USD |
| Total Cash Per Share (mrq) | 0.28 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.294 |
| Book Value Per Share (mrq) | 0.174 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7135000 USD |
| Levered Free Cash Flow (ttm) | -4315000 USD |
Profile of Vallon Pharmaceuticals
| Country | United States |
| State | PA |
| City | Philadelphia |
| Address | Two Logan Square |
| ZIP | 19103 |
| Phone | 267 607 8255 |
| Website | https://www.vallon-pharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
As of April 21, 2023, Vallon Pharmaceuticals, Inc. was acquired by GRI Bio, Inc., in a reverse merger transaction. Vallon Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. The company's lead investigational product candidate is ADAIR (Abuse-Deterrent Amphetamine Immediate-Release), an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. It is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. The company was incorporated in 2018 and is based in Philadelphia, Pennsylvania.
Q&A For Vallon Pharmaceuticals Stock
What is a current VLON stock price?
Vallon Pharmaceuticals VLON stock price today per share is 0.4 USD.
How to purchase Vallon Pharmaceuticals stock?
You can buy VLON shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vallon Pharmaceuticals?
The stock symbol or ticker of Vallon Pharmaceuticals is VLON.
Which industry does the Vallon Pharmaceuticals company belong to?
The Vallon Pharmaceuticals industry is Biotechnology.
How many shares does Vallon Pharmaceuticals have in circulation?
The max supply of Vallon Pharmaceuticals shares is 0.
What is Vallon Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Vallon Pharmaceuticals PE Ratio is 0.00000000 now.
What was Vallon Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Vallon Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Vallon Pharmaceuticals company belong to?
The Vallon Pharmaceuticals sector is Healthcare.
Vallon Pharmaceuticals VLON included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16307.16 USD — |
-3.07
|
7.08B USD — | 16066.46 USD — | 16600.37 USD — | — - | 7.08B USD — |
| NASDAQ HealthCare IXHC | 882.43 USD — |
-1.77
|
— — | 875.25 USD — | 895.82 USD — | — - | — — |
- {{ link.label }} {{link}}